Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2HI8

human formylglycine generating enzyme, C336S mutant, bromide co-crystallization

Summary for 2HI8
Entry DOI10.2210/pdb2hi8/pdb
DescriptorSulfatase-modifying factor 1, CTPSR, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (7 entities in total)
Functional Keywordshydrolase activator, protein binding, formylglycin generation, post-translational modification, endoplasmic reticulum, sulfatase
Biological sourceHomo sapiens (human)
More
Cellular locationEndoplasmic reticulum lumen: Q8NBK3
Total number of polymer chains2
Total formula weight34412.83
Authors
Rudolph, M.G.,Roeser, D. (deposition date: 2006-06-29, release date: 2007-05-01, Last modification date: 2024-10-30)
Primary citationRoeser, D.,Schmidt, B.,Preusser-Kunze, A.,Rudolph, M.G.
Probing the oxygen-binding site of the human formylglycine-generating enzyme using halide ions.
Acta Crystallogr.,Sect.D, 63:621-627, 2007
Cited by
PubMed Abstract: The catalytic residue in sulfatases is a unique formylglycine that is post-translationally generated by oxidation of a cysteine or serine precursor. Molecular oxygen oxidizes the cysteine precursor in eukaryotic sulfatases, a reaction that is catalysed by the formylglycine-generating enzyme FGE. Previously, FGE was crystallized in complex with a chloride ion which, based on its similar polarizability and hydrophobicity, indicates the site of molecular oxygen binding. Here, two structures of FGE in complex with bromide and iodide were determined in order to further delineate the volume and stereochemical restraints of the oxygen-binding site for potential reaction intermediates. Anomalous difference density maps unambiguously assigned the nature of the halide ions. Unexpectedly, data collected at a wavelength of 1.54 A from the iodide-containing crystal and data collected at a wavelength of 0.8 A from a bromide-containing crystal were sufficient for SIRAS phasing.
PubMed: 17452787
DOI: 10.1107/S0907444907009961
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.64 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon